Furthermore, summary data-based MR (SMR) method integrating tissue-shared and tissue-specific protein quantitative trait loci (pQTLs) data identified proteins involved in AD risk in neurologically relevant tissues (brain, cerebrospinal fluid, and plasma), showing that variants in the CD33 locus were associated with plasma CD33 protein levels and AD risk [18]. This evidence concerns the gene CD33 and Alzheimer disease.